Keep Me Logged In
Salix Pharmaceuticals has agreed to merge with Cosmo Pharmaceuticals. CNBC's David Faber and Jim Cramer discuss the growing trend of U.S companies shifting their tax domiciles abroad and why the Salix deal is worth keeping an eye on.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2018 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by